Patrick Soon-Shiong opens trial for Bioshield in long Covid treatment

Patrick Soon-Shiong opens trial for Bioshield in long Covid treatment
@DrPatSoonShiong: Soon-Shiong opens Bioshield trial

Patrick Soon-Shiong, a renowned healthcare entrepreneur, has announced the opening of a trial for Bioshield, aimed at exploring treatments for long Covid.

Interested parties are encouraged to submit their enquiries through the designated form provided in the announcement. The trial signifies a significant step towards addressing the growing concerns surrounding long Covid, which has continued to impact many individuals globally. Soon-Shiong has emphasized the importance of this trial in advancing treatment options for affected patients. The Bioshield research is linked with the hashtag #anktiva, indicating its potential relevance in therapeutic development.

Soon-Shiong’s dedication to advancing patient care through innovative research has long been evident, reflecting broader themes explored in his discussions regarding healthcare priorities with Senator Bill Cassidy and an unwavering focus on patient and national welfare. Further context on these initiatives can be found in his analysis of healthcare commitment.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.